Subtopic Deep Dive

Fracture Risk Assessment in Osteoporosis
Research Guide

What is Fracture Risk Assessment in Osteoporosis?

Fracture Risk Assessment in Osteoporosis develops and validates tools like FRAX that integrate bone mineral density, clinical risk factors, and country-specific probabilities to predict fragility fracture risk.

FRAX estimates 10-year risk of hip and major osteoporotic fractures without requiring BMD in some cases (Kanis et al., 2008). Russian studies highlight high osteoporosis prevalence and hip fracture mortality (Lesnyak et al., 2018; 91 citations; Ershova et al., 2015; 15 citations). Recent work explores machine learning models for second hip fracture prediction (Larrainzar-Garijo et al., 2024; 12 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

FRAX guides screening and treatment decisions to prevent hip fractures, which cause high mortality in Russia (Ershova et al., 2015). Virtual fracture liaison services maintain prevention during pandemics (English et al., 2021; 24 citations). Models like those in Larrainzar-Garijo et al. (2024) predict secondary fractures using EHR data, optimizing pharmacotherapy. National guidelines integrate risk assessment for chronic disease prevention (Drapkina et al., 2022; 104 citations).

Key Research Challenges

Country-Specific Validation

FRAX requires adaptation for local populations, as Ukrainian hip fracture epidemiology differs from Western data (Povoroznyuk et al., 2018; 14 citations). Russian studies show unique prevalence patterns (Lesnyak et al., 2018; 91 citations). Validation needs large cohorts for accuracy.

Hip Fracture Mortality Modeling

Predicting post-hip fracture mortality remains challenging due to multifactorial risks (Ershova et al., 2015; 15 citations). Geriatric assessments aid but lack integration with fracture tools (Sharashkina et al., 2023; 10 citations). Data scarcity hinders precise models.

Secondary Fracture Prediction

Machine learning on EHRs for second hip fractures faces data quality issues (Larrainzar-Garijo et al., 2024; 12 citations). Incorporating BMD and treatments like denosumab adds complexity (Belaya et al., 2018; 18 citations). Real-world validation is limited.

Essential Papers

1.

Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. Ten years later

S. А. Boytsov, О. М. Драпкина, Е. V. Shlyakhto et al. · 2021 · CARDIOVASCULAR THERAPY AND PREVENTION · 112 citations

The growing weight of noncommunicable diseases, primarily cardiovascular diseases (CVDs), is a great threat to the health of population worldwide, worsening the quality of life and reducing life ex...

2.

2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines

О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина et al. · 2022 · CARDIOVASCULAR THERAPY AND PREVENTION · 104 citations

.

3.

OSTEOPOROSIS IN RUSSIAN FEDERATION: EPIDEMIOLOGY, SOCIO-MEDICAL AND ECONOMICAL ASPECTS (REVIEW)

O. M. Lesnyak, И. А. Баранова, K. Yu. Belova et al. · 2018 · Traumatology and Orthopedics of Russia · 91 citations

The authors performed an analysis of published stadies devoted to osteoporosis situation in Russian Federation including epidemiological, social, medical and economical aspects of this pathology. T...

4.

Russian Society for the Prevention of Noncommunicable Diseases (ROPNIZ). Alimentary-dependent risk factors for chronic non-communicable diseases and eating habits: dietary correction within the framework of preventive counseling. Methodological Guidelines

О. М. Драпкина, N. S. Karamnova, А. V. Kontsevaya et al. · 2021 · CARDIOVASCULAR THERAPY AND PREVENTION · 41 citations

The methodological guidelines are developed as a practical document for medical specialists working in the field of preventive medicine, in order to expand and improve the provision of this type of...

6.

Long-term treatment options for postmenopausal osteoporosis: results of recent clinical studies of Denosumab

Zhanna Belaya, John P. Bilezikian, О. Б. Ершова et al. · 2018 · Osteoporosis and Bone Diseases · 18 citations

Modern medications for osteoporosis (bisphosphonates, denosumab, teriparatide) are well-tolerated drugs, which can significantly lower vertebral and non-vertebral fracture risk according to prospec...

7.

ANALYSIS OF MORTALITY IN PATIENTS WITH A FRACTURE OF THE PROXIMAL FEMUR

О. Б. Ершова, K. Yu. Belova, A A Degtyarev et al. · 2015 · Osteoporosis and Bone Diseases · 15 citations

Introduction. Hip fracture (HF) are the most serious complication of osteoporosis and a serious public health problem, causing significant economic damage. They are characterized by a high level of...

Reading Guide

Foundational Papers

Start with Kanis et al. (2008) for FRAX methodology, then Povoroznyuk et al. (2014) for early Eastern European validation to build core risk assessment framework.

Recent Advances

Study Lesnyak et al. (2018; 91 citations) for Russian epidemiology, Larrainzar-Garijo et al. (2024; 12 citations) for ML prediction, and English et al. (2021; 24 citations) for liaison services.

Core Methods

Core methods include FRAX algorithm (Kanis et al., 2008), Cox regression for mortality (Ershova et al., 2015), and NLP/ML on EHRs (Larrainzar-Garijo et al., 2024).

How PapersFlow Helps You Research Fracture Risk Assessment in Osteoporosis

Discover & Search

Research Agent uses searchPapers and exaSearch to find Russian osteoporosis epidemiology papers like Lesnyak et al. (2018; 91 citations), then citationGraph reveals connections to FRAX adaptations (Kanis et al., 2008) and findSimilarPapers uncovers Povoroznyuk et al. (2018).

Analyze & Verify

Analysis Agent applies readPaperContent to extract FRAX algorithms from Kanis et al. (2008), verifies risk models with verifyResponse (CoVe), and uses runPythonAnalysis for statistical comparison of hip fracture rates in Ershova et al. (2015) vs. Larrainzar-Garijo et al. (2024) with GRADE grading for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in Russian FRAX validation via gap detection, flags contradictions between regional data (Lesnyak et al., 2018) and global tools, while Writing Agent uses latexEditText, latexSyncCitations for Lesnyak et al., and latexCompile to produce reports with exportMermaid diagrams of risk factor flows.

Use Cases

"Compare hip fracture incidence rates in Russia vs Ukraine using recent data"

Research Agent → searchPapers('hip fracture epidemiology Russia Ukraine') → Analysis Agent → runPythonAnalysis(pandas on extracted rates from Lesnyak 2018 and Povoroznyuk 2018) → matplotlib plot of incidence differences.

"Draft a LaTeX review on FRAX validation in Eastern Europe"

Synthesis Agent → gap detection on FRAX papers → Writing Agent → latexEditText(structured review) → latexSyncCitations(Kanis 2008, Povoroznyuk 2014) → latexCompile → PDF with risk assessment flowchart.

"Find code for machine learning hip fracture prediction models"

Research Agent → searchPapers('predictive model hip fracture') → Code Discovery → paperExtractUrls(Larrainzar-Garijo 2024) → paperFindGithubRepo → githubRepoInspect → runnable ML scripts for EHR-based prediction.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ FRAX-related papers: searchPapers → citationGraph → GRADE grading → structured report on Russian adaptations. DeepScan analyzes hip fracture mortality (Ershova 2015) via 7-step chain: readPaperContent → runPythonAnalysis(survival curves) → CoVe verification. Theorizer generates hypotheses on denosumab's risk reduction from Belaya et al. (2018).

Frequently Asked Questions

What is FRAX in fracture risk assessment?

FRAX calculates 10-year probability of hip and major osteoporotic fractures using clinical risks and optional BMD (Kanis et al., 2008).

What methods validate fracture risk tools?

Validation uses cohort studies comparing predicted vs. observed fractures, as in Ukrainian epidemiology (Povoroznyuk et al., 2018) and machine learning on EHRs (Larrainzar-Garijo et al., 2024).

What are key papers on osteoporosis in Russia?

Lesnyak et al. (2018; 91 citations) reviews epidemiology; Ershova et al. (2015; 15 citations) analyzes hip fracture mortality.

What are open problems in this subtopic?

Adapting FRAX for regional differences, predicting secondary fractures with ML, and integrating geriatric assessments remain unsolved (Povoroznyuk et al., 2018; Larrainzar-Garijo et al., 2024).

Research Healthcare Systems and Public Health with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Fracture Risk Assessment in Osteoporosis with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.